Table 1

Demographic and biochemical characteristics between groups (n=54)

VariableNGT (n=10)IGT (n=15)T2D− (n=12)T2D+ (n=17)P value*Tukey post hoc analysis
Age, years59 (8)57 (5)58 (3)63 (8)0.08
Male sex3 (30%)6 (40%)3 (25%)8 (47%)0.65
Anthropometric measurements
Weight, kg84.3 (15)91.6 (14)91.5 (18)85.6 (11)0.4
Body mass index, kg/m229.6 (5)31.6 (2)32 (4)30 (5)0.3
Clinic hemodynamic measurements
Systolic blood pressure, mm Hg135 (14)122 (14)133 (20)136 (13)0.04
Diastolic blood pressure, mm Hg76 (7)69 (8)71 (11)78 (12)0.05
Heart rate, beats per minute64 (7)63 (9)60 (10)74 (12)0.002†, ‡
Fasting lipid profile, mmol/L
Total cholesterol5.9 (1)5.3 (0.9)5.6 (0.7)4.2 (1)0.0001††, ‡, §
High-density lipoprotein1.5 (0.3)2.5 (1)1.9 (1)1.3 (0.3)0.001†, ¶
Low-density lipoprotein3.8 (0.9)2.1 (1)2.9 (1.5)2.2 (1)0.002§, ¶
Triglyceride1.4 (0.5)1.5 (0.8)1.7 (0.7)1.7 (0.9)0.6
Fasting serum glucose mmol/L5.0 (0.5)5.4 (0.5)5.98 (1.6)6.9 (1.9)0.02
HbA1c %(mmol/mol)7.2 (55) (1.72)
CRP, mg/ L2.1 (1.6)2.3 (1.8)2.8 (1.6)1.9 (1)0.4
24 hours urine biochemistry excretion
Sodium, mmol/24 hours (range)111 (20) (71–148)122 (23) (73–150)98 (27) (50–133)110 (26) (36–145)0.1
Potassium, mmol/24 hours (range)70 (21) (36–98.5)87 (24) (49–144)74 (21) (48–118)72 (30) (35–134)0.3
  • Data is expressed as mean (SD) or number (percentage) as indicated.

  • The following symbols indicate Tukey post hoc significance: (†) IGT versus T2D+; (‡) T2D− versus T2D+; (§) NGT versus T2D+; (¶) NGT versus IGT; (**) NGT versus T2D−; (††) IGT versus T2D−

  • *The p values are derived from one-way analysis of variance. Bold values indicate statistical significance.

  • BEI, baroreflex effectiveness index; HbA1c, glycosylated hemoglobin A1c; IGT, impaired glucose tolerance; MSNA, muscle sympathetic nerve activity; PAT, pulse amplitude tonometry; RHI, Reactive Hyperemic Index; T2D−, treatment naive type 2 diabetes; T2D+, treated type 2 diabetes.